SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the first publication ...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ...
Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor DNA assay. Safety and activity of DCR-MYC, a first-in-class Dicer-substrate small interfering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results